F/M Investments’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$787K Buy
52,546
+702
+1% +$10.5K 0.03% 306
2025
Q1
$837K Buy
51,844
+3,038
+6% +$49K 0.03% 303
2024
Q4
$1.14M Buy
+48,806
New +$1.14M 0.04% 277